A health worker organises samples collected for further testing at Thanon Mitr Market, amid the spread of the coronavirus disease , in Bangkok, Thailand, January 19, 2021. REUTERS/Chalinee Thirasupa
He said that royally-owned Siam Bioscience had been the most obvious choice of many companies considered for technology transfer from pharmaceutical firm AstraZeneca to make 200 million vaccine doses each year for Thailand and other nations. Thanathorn made his comments on Facebook Live on Monday at an event titled “Royal Vaccine: Who Benefits and Who Doesn’t?”
Hemos resumido esta noticia para que puedas leerla rápidamente. Si estás interesado en la noticia, puedes leer el texto completo aquí. Leer más:
México Últimas Noticias, México Titulares
Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.
Thailand defends royal company's role in vaccine strategyThailand’s government defended its coronavirus vaccine strategy on Tuesday against opposition criticism that it is too reliant on a company owned by King Maha Vajiralongkorn.
Fuente: Reuters - 🏆 2. / 97 Leer más »
A New Covid-19 Battle Plan From Asia: Letting Companies Buy VaccinesWith vaccinations lagging, Indonesia’s government has authorized private companies to acquire Covid-19 vaccines, but some public-health experts say the strategy will steer shots toward the middle-class and wealthy. In Brazil, the same shit will soon be done Make no mistake, the vaccines will always find a way in to the arms of the wealthy before anyone else. Companies will use different vaccines from Government Programme !
Fuente: WSJ - 🏆 98. / 63 Leer más »